Harold H. Shlevin, Chief Operating Officer at GALECTIN THERAPEUTICS INC (GALT), bought 500 shares at $6.63 ($3K) on 2013-11-18, disclosed to the SEC on 2013-11-19.
Open-market purchase of $3k GALT by Chief Operating Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| GALT | SELL | 2025-12-16 | $354K | — | Filing → |
| GALT | SELL | 2025-12-10 | $1.3M | — | Filing → |
| GALT | BUY | 2024-12-31 | $8K | — | Filing → |